biosig_rgb.png
New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias
May 19, 2023 07:30 ET | BioSig Technologies, Inc.
Data from three abstracts highlight the potential of an optimized radiofrequency ablation technique for pulmonary vein isolation (PVI) Preservation of raw unipolar signal using BioSig’s...
biosig_rgb.png
BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023
May 03, 2023 09:00 ET | BioSig Technologies, Inc.
Westport, CT, May 03, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
TIP_link_300x300.jpg
Atrial Fibrillation Market Worth $20.92 Billion, Globally, by 2028 at 14.11% CAGR | The Insight Partners
April 04, 2023 09:45 ET | The Insight Partners
Pune, INDIA., April 04, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Atrial Fibrillation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Treatment Type, End User,...
biosig_rgb.png
BioSig Announces New Advisory Board Member Edwin Wang
March 27, 2023 08:38 ET | BioSig Technologies, Inc.
Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Announces New Advisory Board Member Lorraine Spurge
March 24, 2023 08:30 ET | BioSig Technologies, Inc.
Westport, CT, March 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Confirms No Exposure to Silicon Valley Bank
March 13, 2023 07:30 ET | BioSig Technologies, Inc.
Westport, CT, March 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Regains Compliance With All Nasdaq Listing Standards
February 22, 2023 07:30 ET | BioSig Technologies, Inc.
Westport, CT, Feb. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Awarded US Patent Claims for its Universal Notch Filter Technology
February 17, 2023 07:30 ET | BioSig Technologies, Inc.
Westport, CT, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Patent can remove any fixed frequency interfering with original signal of interest preserving critical intracardiac dataBioSig now has 56 worldwide...
biosig_rgb.png
BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy
February 07, 2023 08:00 ET | BioSig Technologies, Inc.
Westport, CT, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Chief Financial Officer Steve Chaussy retires following 12 years of serviceSteve Buhaly joins BioSig as CFOBuhaly brings 15 years of public company...
biosig_rgb.png
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
January 19, 2023 08:30 ET | BioSig Technologies, Inc.
Westport, CT, Jan. 19, 2023 (GLOBE NEWSWIRE) -- To date, the Company's FDA 510(k)-cleared PURE EP™ System has been used in approximately 3,000 patient cases across the United States The...